Tadaflo 5 mg (Tadalafil)

Product Overview

Tadaflo 5 mg is a pharmaceutical formulation containing the active ingredient Tadalafil, manufactured by Cipla Limited. It is indicated for the treatment of erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). The product is supplied in blister packs of 15 tablets, with pack sizes available in 60, 90, and 120 tablets. Tadaflo belongs to the class of phosphodiesterase‑5 (PDE‑5) inhibitors and works by enhancing blood flow to the penis in men with ED and reducing pulmonary vascular resistance in patients with PAH.

What is Tadaflo 5 mg (Tadalafil)

Tadalafil is a selective inhibitor of the phosphodiesterase‑5 enzyme, which plays a key role in regulating smooth‑muscle tone in various tissues. By blocking PDE‑5, Tadalafil increases cyclic guanosine monophosphate (cGMP) levels, leading to relaxation of vascular smooth muscle and improved blood flow. This mechanism underlies its efficacy in both erectile dysfunction and pulmonary arterial hypertension. The medication is classified as a prescription drug and should be used only under medical supervision.

Uses and Benefits

Clinically, Tadaflo 5 mg is prescribed to men who experience difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity. In the context of PAH, it helps to lower pulmonary arterial pressure, thereby improving exercise capacity and delaying disease progression. The therapeutic benefits include improved sexual function, increased exercise tolerance, and potential reduction in hospitalization rates for PAH patients. Real‑world studies have demonstrated that consistent use of Tadalafil can lead to statistically significant improvements in International Index of Erectile Function (IIEF) scores and six‑minute walk distance in PAH cohorts.

How It Works

The pharmacodynamics of Tadalafil involve selective binding to the PDE‑5 enzyme in the corpora cavernosa of the penis and in the pulmonary vasculature. Inhibition of PDE‑5 prevents the breakdown of cGMP, allowing the nitric oxide‑mediated signaling cascade to remain active. This results in smooth‑muscle relaxation and vasodilation. The onset of action typically occurs within 30 to 60 minutes after oral administration, with a duration of effect that can extend up to 36 hours, providing a flexible dosing window for patients.

Dosage Guidelines

For erectile dysfunction, the recommended starting dose of Tadaflo is 5 mg taken orally as needed, approximately 30 minutes before anticipated sexual activity. Depending on individual response and tolerability, the dose may be increased to 10 mg or decreased to 2.5 mg. Patients with PAH are typically prescribed 20 mg once daily, but the 5 mg strength is also used in certain low‑dose regimens. It is important to note that Tadaflo should not be taken more than once per day and should not be combined with nitrates or certain alpha‑blockers without medical advice. Always consult a qualified healthcare provider to determine the appropriate dose for your specific condition.

Side Effects

Like all medications, Tadaflo may cause adverse effects. The most commonly reported side effects include headache, flushing, dyspepsia, back pain, myalgia, and nasal congestion. These events are generally mild to moderate and transient. Less frequent but more serious adverse events can include sudden vision loss, hearing impairment, priapism (a prolonged erection lasting more than four hours), and cardiovascular events such as angina or arrhythmia. Patients experiencing any of these serious symptoms should seek immediate medical attention. For a comprehensive list of side effects, refer to the FDA’s drug label or consult a pharmacist.

Warnings and Precautions

Tadaflo is contraindicated in patients with known hypersensitivity to Tadalafil or any of the excipients. Caution should be exercised in individuals with severe hepatic or renal impairment, uncontrolled hypertension, or recent cardiovascular events such as myocardial infarction or stroke. Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) may increase systemic exposure and require dose adjustment. Alcohol consumption should be limited, as it can exacerbate hypotension. Patients with retinitis pigmentosa or a history of non‑arteritic anterior ischemic optic neuropathy (NAION) should discuss potential risks with their physician before initiating therapy.

Frequently Asked Questions

1. Can Tadaflo be taken with food? Yes, Tadaflo can be taken with or without food. However, a high‑fat meal may delay the onset of action.
2. How long does the effect of Tadaflo last? The therapeutic effect can persist for up to 36 hours, which is longer than many other PDE‑5 inhibitors.
3. Is Tadaflo safe for daily use? For most men with ED, a daily low‑dose regimen (2.5 mg or 5 mg) is considered safe, but it should only be used under medical guidance.
4. Can women use Tadaflo? Tadaflo is not indicated for female patients and should not be used during pregnancy or breastfeeding without a physician’s recommendation.
5. Where can I find more information about Tadalafil? Reliable details are available from sources such as the NIH, PubMed, the FDA, and MedlinePlus. For a broader overview, see the Wikipedia entry.